Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (131-140 of 243) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapiesRenaud La Joie, Jeffrey L Cummings, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2011
Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010Zaven S Khachaturian, Ronald C Petersen, Peter J Snyder, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2021
Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemicEmily A Meyers, Philippe Amouyel, Diane E Bovenkamp, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable WorkgroupReisa A Sperling, Clifford R Jack, Sandra E Black, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple CohortsJoseph Giorgio, Ganna Blazhenets, Susan M Landau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumJoseph Giorgio, Ganna Blazhenets, Jhony A Mejía-Perez, et al.
Pageof 25

Showing results (131-140 of 243) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapiesRenaud La Joie, Jeffrey L Cummings, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2011
Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010Zaven S Khachaturian, Ronald C Petersen, Peter J Snyder, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2021
Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemicEmily A Meyers, Philippe Amouyel, Diane E Bovenkamp, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable WorkgroupReisa A Sperling, Clifford R Jack, Sandra E Black, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple CohortsJoseph Giorgio, Ganna Blazhenets, Susan M Landau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumJoseph Giorgio, Ganna Blazhenets, Jhony A Mejía-Perez, et al.
Pageof 25